Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2023 Nov. 13 [cited 2026 May 1];7(6):s279. Available from: https://skin.dermsquared.com/skin/article/view/2389